ICAM1 and acute respiratory distress syndrome: We will also review potential therapeutic approaches that may (1) utilize increased transcytotic activity during ALI/ARDS for drug delivery or (2) limit endothelial transcytosis by inhibiting platelet activation and subsequent ICAM1 expression on endothelial cells.